Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T09:43:54.268Z Has data issue: false hasContentIssue false

Intraventricular Neurocysticercosis Managed with Albendazole and Dexamethasone

Published online by Cambridge University Press:  02 December 2014

Jan Hajek*
Affiliation:
Division of Infectious Diseases, North York General Hospital, University of Toronto, Toronto, Ontario, Canada
Jay Keystone
Affiliation:
Tropical Disease Unit, Division of Infectious Diseases, The Toronto Hospital, University of Toronto, Toronto, Ontario, Canada
*
Department of Infectious Diseases, North York General Hospital, 4001 Leslie Street, GW-33, Toronto, Ontario, M2K 1E1, Canada.
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1.Carpio, A.Neurocysticercosis: an update. Lancet Infect Dis. 2002;2: 75162.Google Scholar
2.Schantz, PM, Cruz, M, Sarti, E, Pawlowski, Z.Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ. 1993;27(4):397403.Google Scholar
3.Nash, TE, Singh, G, White, AC, Rajshekhar, V, Loeb, JA, Proano, JV, et al.Treatment of neurocysticercosis: current status and future research needs. Neurology. 2006 Oct 10;7(1120):7.Google Scholar
4.Cuetter, AC, Andrews, RJ.Intraventricular neurocysticercosis: a series of 18 consecutive patients and review of the literature. Neurosurg Focus. 2002;12(6):e5.CrossRefGoogle ScholarPubMed
5.Allcut, DA, Coulthard, A.Neurocysticercosis: regression of a fourth ventricular cyst with praziquantel. J Neurol Neurosurg Psychiatry. 1991 May;5(461):2.Google Scholar
6.Fandino, J, Botana, C, Fandino, C, Rodriguez, D, Gomez-Bueno, J.Clinical and radiographic response of fourth ventricle cysticercosis to praziquantel therapy. Acta Neurochir. 1991;111(3-4):1357.CrossRefGoogle ScholarPubMed
7.del Brutto, OH, Sotelo, J.Albendazole therapy for subarachnoid and ventricular cysticercosis. Case report. J Neurosurg. 1990 May; 5(816):7.Google Scholar
8.Gongora-Rivera, F, Soto-Hernandez, JL, Gonzalez Esquivel, D, Cook, HJ, Marquez-Caraveo, C, Hernandez Davila, R, et al.Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology. 2006 Feb 14;3(436):8.Google Scholar
9.Proaño, JV, Madrazo, I, García, L, García-Torres, E, Correa, D.Albendazole and praziquantel treatment in neurocysticercosis of the fourth ventricle. J Neurosurg. 1997;87:2933.CrossRefGoogle ScholarPubMed
10.Torres-Corzo, J, Rodriguez-della Vecchia, R, Rangel-Castilla, L.Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy. J Neurosurg. 2006 May;5(746):8.Google Scholar
11.Garcia, HH, Evans, CA, Nash, TE, Takayanagui, OM, White, AC Jr, Botero, D, et al.Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002 Oct;4(747):56.Google Scholar
12.del Brutto, OH, Roos, KL, Coffey, CS, García, HH.Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med. 2006 Jul 4;1(43):51.Google Scholar
13.Sotelo, J, del Brutto, OH, Penagos, P, Escobedo, F, Torres, B, Rodriguez-Carbajal, J, et al.Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J. Neurol. 1990;237:6972.Google Scholar
14.Colli, BO, Carlotti, CG Jr, Assirati, JA Jr, Machado, HR, Valenca, M, Amato, MC.Surgical treatment of cerebral cysticercosis: long-term results and prognostic factors. Neurosurg Focus. 2002 Jun 15;12(6):e3.Google Scholar
15.Suastegui Roman, RA, Soto-Hernández, JL, Sotelo, J.Effects of prednisone on ventriculoperitoneal shunt function in hydrocephalus secondary to cysticercosis: a preliminary study. J Neurosurg. 1996;84:62933.CrossRefGoogle ScholarPubMed